
PLX
Healthcare · Biotechnology · $257.2M market cap
$3.05+0.09 (+3.0%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -50.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2026 | Before the open | -0.02 | 0.05 | +350.0% |
| Aug 12, 2026 | Before the open | -0.01 | 0.05 | +600.0% |
| May 13, 2026 | Before the open | -0.01 | 0.22 | +2300.0% |
| Mar 12, 2026 | Time not confirmed | 0.04 | -0.07 | -300.0% |
| Nov 13, 2025 | Before the open | 0.06 | 0.03 | -50.0% |
| Aug 14, 2025 | Before the open | 0.03 | -0.04 | -233.3% |
| May 9, 2025 | Before the open | 0.08 | -0.05 | -162.5% |
| Mar 12, 2025 | Before the open | 0.07 | 0.09 | +28.6% |
| Nov 14, 2024 | Before the open | 0.06 | 0.03 | -50.0% |
| Aug 14, 2024 | Before the open | 0.02 | -0.03 | -250.0% |
| May 10, 2024 | Before the open | -0.02 | -0.06 | -200.0% |
| Mar 14, 2024 | Before the open | -0.03 | -0.07 | -133.3% |
| Nov 6, 2023 | Before the open | -0.07 |
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115,…
| -0.03 |
| +57.1% |
| Aug 7, 2023 | Before the open | -0.04 | 0.21 | +625.0% |
| May 4, 2023 | Before the open | -0.05 | -0.05 | 0.0% |
| Feb 27, 2023 | Before the open | -0.15 | -0.07 | +53.3% |
| Nov 14, 2022 | Before the open | -0.15 | -0.07 | +53.3% |
| Aug 15, 2022 | Before the open | -0.18 | -0.11 | +38.9% |
| May 16, 2022 | Before the open | -0.04 | -0.05 | -25.0% |
| Mar 31, 2022 | Before the open | -0.11 | -0.15 | -36.4% |
| Nov 15, 2021 | Before the open | -0.12 | -0.09 | +25.0% |
| Aug 16, 2021 | Before the open | -0.10 | -0.25 | -150.0% |
| May 14, 2021 | Before the open | -0.17 | -0.14 | +17.6% |
| Mar 30, 2021 | Before the open | -0.08 | 0.01 | +112.5% |
| Oct 29, 2020 | Before the open | -0.08 | -0.14 | -75.0% |
| Aug 10, 2020 | Before the open | -0.20 | -0.13 | +35.0% |
| Jun 1, 2020 | Before the open | -0.30 | 0.10 | +133.3% |
| Mar 12, 2020 | After the close | -0.63 | 0.01 | +101.6% |
| Nov 7, 2019 | Before the open | -0.35 | -0.20 | +42.9% |
| Aug 8, 2019 | Before the open | -0.30 | -0.50 | -66.7% |
| May 6, 2019 | Before the open | -0.25 | -0.50 | -100.0% |
| Mar 18, 2019 | Before the open | -0.45 | -0.37 | +17.8% |
| Nov 7, 2018 | Before the open | -0.40 | -1.00 | -150.0% |
| Aug 9, 2018 | Before the open | -0.40 | -0.80 | -100.0% |
| May 9, 2018 | Before the open | -0.90 | -0.60 | +33.3% |
| Mar 6, 2018 | Before the open | -0.60 | -0.60 | 0.0% |